Safety and efficacy of S-1-based treatment in colorectal cancer patients who switched to S-1 after development of cardiotoxicity on fluoropyrimidine-based adjuvant or neoadjuvant treatment
Event: ESC Cardio-Oncology 2025
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Session: Prevention of cancer therapy-related cardiovascular disease
